GlycoSeLect Ltd Ireland

Our company develops and manufactures technology and applications for glycoprotein separation and analysis. We are focussed on the biopharmaceutical industry. We also have customers in medical diagnostic and cosmetic companies.
Our facility is based on the campus of Dublin City University in Ireland.
We have developed an extensive network of contacts not only customers but also opinion leaders in glybiology.

Website:
GlycoSeLect Ltd
Company Size (Fulltime employees)
Year of foundation
2013
Please specify your partnering goal
Joint venture to develop downstream processing applications
Funding Status
Series A
Now raising (In USD)
900,000
Headquartner in China
Plan in China
Seek local partner to establish glycobiology specialist company supplying better glycoprotein product analysis and manufacturing technology with support for application development.
Biotech/Pharma Category
Assets Information 1: Name|Description|Indications|Stage|IP countries
RPL lectins for glycoprotein product analysis & manufacturing applications|Glycan specific proteins for use in detecting and separating glycoproteins|Product analysis and manufacturing, especially vaccines and mAbs.|Worldwide available
Biotech/Pharma Asset Stage
Slides Deck
(pdf, 164.08KB)
Robert Dunne
CEO 
Functionality